Avanir Pharmaceuticals Inc (NASDAQ:AVNR) Investor Alert: Lawsuit Against Takeover Filed
December 08, 2014 at 08:30 AM EST
San Diego, CA -- (ReleaseWire) -- 12/08/2014 -- An investor, who currently holds shares of Avanir Pharmaceuticals Inc (NASDAQ:AVNR filed a lawsuit in effort to halt the proposed takeover of Avanir Pharmaceuticals Inc by Otsuka Pharmaceutical Co for $17.00 per share.